 |
市場調査レポート
商品コード
1458089
除細動器の世界市場規模、シェア、成長分析、製品別、エンドユーザー別 - 産業予測、2024年～2031年Global Defibrillator Market Size, Share, Growth Analysis, By Product(Implantable Cardioverter Defibrillators (ICD), and External Defibrillators (ED)), By End-User(Hospital, Pre-Hospital) - Industry Forecast 2024-2031 |
||||||
| 除細動器の世界市場規模、シェア、成長分析、製品別、エンドユーザー別 - 産業予測、2024年～2031年 |
|
出版日: 2024年03月29日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
除細動器の世界市場規模は2022年に127億6,000万米ドルと評価され、予測期間（2024年～2031年）のCAGRは7.20%で、2023年の136億8,000万米ドルから2031年には238億6,000万米ドルに成長する見通しです。
同市場の成長は、製品技術の進歩、突然の心停止事例の増加、社会意識の高まり、政府やヘルスケア機関の支援策など、いくつかの重要な要因によって後押しされています。この進歩の一例として、オーストラリアのRapid Response Revival Research Ltd.が、家庭用に設計された世界初の個人用AEDである画期的なCellAEDのCE認証を2021年に取得したことが挙げられます。予防と治療における進歩にもかかわらず、突然の心停止は依然として心血管系死亡の重大な要因であるため、技術革新が促進され、植込み型除細動器（ICD）や体外式除細動器の需要が高まっています。例えば、Ami Italiaは、Saver One、Geo Saver、Smarty Saverラインなどの除細動器を提供しており、汎用性の高いSmartyシリーズは、緊急車両、医療施設、公共スペースなどさまざまな場面で使用され、医療従事者と非医療従事者の両方に対応しています。一方、Microportは中国の心臓リズム管理市場を独占しており、その多様な製品ポートフォリオと強力なパイプラインにより、2022年上半期に95％の大幅な収益急増を記録しました。さらに、ドバイ救急サービス公社（DCAS）が市内のさまざまな場所に80台のAEDを配布しているような取り組みや、DCASのHelp Meアプリを通じて熟練した対応者のネットワークを確立することを目的としたThis Town Saves Nowのようなプログラムを通じたボランティア訓練によって補完されています。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- 二次データソースと一次データソース
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
除細動器の世界市場：製品別
- 市場概要
- 植込み型除細動器（ICD）
- 体外式除細動器（ED）
除細動器の世界市場：エンドユーザー別
- 市場概要
- 病院
- 入院前
- パブリックアクセスマーケット
- 代替医療市場
- 在宅ヘルスケア
除細動器の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Medtronic plc
- Philips Healthcare
- Abbott Laboratories
- Boston Scientific Corporation
- ZOLL Medical Corporation
- Physio-Control, Inc.（a Stryker Company）
- Cardiac Science Corporation
- Nihon Kohden Corporation
- Koninklijke Philips NV.
- SCHILLER AG
- CU Medical Systems, Inc.
- Progetti S.r.l.
- Mindray Medical International Limited
- Defibtech, LLC
- LivaNova PLC
- Cardionet, LLC（a BioTelemetry Company）
- Biotronik SE & Co. KG
- Welch Allyn（a Hill Rom Company）
- Cardiac Science Corporation
- Physio-Control, Inc.（a Stryker Company）
Global Defibrillator Market size was valued at USD 12.76 Billion in 2022 and is poised to grow from USD 13.68 Billion in 2023 to USD 23.86 Billion by 2031, at a CAGR of 7.20% during the forecast period (2024-2031).
The growth of the market is being propelled by several key factors, including advancements in product technology, an uptick in sudden cardiac arrest cases, heightened public awareness, and supportive initiatives from governmental and healthcare bodies. An example of this progress is evident in Rapid Response Revival Research Ltd., an Australian company, obtaining CE certification in 2021 for their groundbreaking CellAED, the world's first personal AED designed for home use, which facilitated the company's expansion plans. Despite strides in prevention and treatment, sudden cardiac arrest remains a significant contributor to cardiovascular mortality, fostering innovation and driving demand for implantable cardioverter defibrillators (ICDs) and external defibrillators. Ami Italia, for instance, offers a range of defibrillators like the Saver One, Geo Saver, and Smarty Saver lines, with the versatile Smarty Series finding application in various settings such as emergency vehicles, medical facilities, and public spaces, catering to both medical and non-medical personnel. Meanwhile, Microport dominates China's cardiac rhythm management market, recording a substantial revenue surge of 95% in the first half of 2022, owing to its diverse product portfolio and robust pipeline. Additionally, increasing awareness of cardiovascular diseases in emerging markets is driving market growth, alongside initiatives like the Dubai Corporation for Ambulance Services (DCAS) distributing 80 AEDs to diverse locations across the city, complemented by volunteer training through programs like This Town Saves Now, aimed at establishing a network of skilled responders via DCAS' Help Me app.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Defibrillator Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Defibrillator Market Segmental Analysis
The global defibrillator market is segmented based on product, end user, and region. Based on product, the market is segmented into implantable cardioverter defibrillators (ICD), and external defibrillators (ED). With respect to categorization by end-use, the market is segmented into hospital, pre-hospital, public access market, alternate care market, and home healthcare. Regionwise, the global defibrillator market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Drivers of the Global Defibrillator Market
The surge in specific target diseases is exerting a profound influence on global healthcare. Cardiovascular ailments, encompassing coronary artery disease and cardiac arrest, impact a considerable segment of the world's populace, resulting in a rising mortality rate. In 2021, data from the Centers for Disease Control and Prevention (CDC) linked approximately 695,000 deaths in the United States to cardiovascular diseases. Particularly, coronary artery disease heightens the risk of sudden cardiac death due to arrhythmias. A 2022 report from the Coronary Artery Disease Foundation indicates an annual occurrence of roughly 356,000 out-of-hospital cardiac arrests (OHCA) in the United States. Lifestyle-related factors such as obesity, hypertension, dyslipidemia, and diabetes significantly contribute to the heightened risk of various cardiovascular conditions. Moreover, the global aging populace serves as a pivotal factor driving the escalating prevalence of cardiovascular diseases. Aging correlates with an increased susceptibility to developing ventricular arrhythmias, primarily attributable to the progressive degradation and heightened complexity in the structure and functionality of the heart, thereby fostering a burgeoning prevalence of arrhythmias among the elderly.
Restraints in the Global Defibrillator Market
The adoption of defibrillators, particularly advanced ones such as ICDs and implantable devices, may be hindered by their relatively high costs, which can constrain market expansion, especially in areas with constrained healthcare budgets or insufficient insurance coverage.
Market Trends of the Global Defibrillator Market
The defibrillator market is experiencing swift technological progressions focused on improving device functionality, user-friendliness, and patient results. Prominent advancements involve the incorporation of artificial intelligence (AI) algorithms to enhance the precision of cardiac rhythm detection, wireless connectivity for distant monitoring and data transfer, and upgraded user interfaces for simplified operation.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Defibrillator Market by Product
- Market Overview
- Implantable Cardioverter Defibrillators (ICD)
- and External Defibrillators (ED)
Global Defibrillator Market by End-User
- Market Overview
- Hospital
- Pre-Hospital
- Public Access Market
- Alternate Care Market
- and Home Healthcare
Global Defibrillator Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Philips Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ZOLL Medical Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Physio-Control, Inc. (a Stryker Company)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cardiac Science Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nihon Kohden Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Koninklijke Philips NV.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SCHILLER AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CU Medical Systems, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Progetti S.r.l.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mindray Medical International Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Defibtech, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LivaNova PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cardionet, LLC (a BioTelemetry Company)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biotronik SE & Co. KG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Welch Allyn (a Hill Rom Company)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cardiac Science Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Physio-Control, Inc. (a Stryker Company)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
